| 摘要 |
<p>The use of a vector causing Bcl-2 expression or a temporary increase in Bcl-2 or Bcl-2-type protein activity in one or more organs, to prepare a drug for treating or preventing the acute failure of one or more organs involving an apoptotic process, by at least partially inhibiting the apoptotic signal, is disclosed.</p> |
